Comparable IHC staining of SSTR2 between fibrotic myocardium and the neuroendocrine tumor sample used as possible control suggests that the levels of SSTR2 in ICM samples would be sufficient to be visible by PET, however, this was not directly tested. Here, SSTR2 is linked to neuroendocrine neoplasm.